Evidence map›Paper›PMID 28700914›Full record

ArticleBiophysical journal2017

Period Robustness and Entrainability of the Kai System to Changing Nucleotide Concentrations.

Joris Paijmans, David K Lubensky, Pieter Rein Ten Wolde

Abstract read
In one paragraph

Article in Biophysical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joris PaijmansAMOLF, Amsterdam, the Netherlands, University of Michigan, Ann Arbor, Michigan.
David K LubenskyDepartment of Physics, University of Michigan, Ann Arbor, Michigan.
Pieter Rein Ten WoldeAMOLF, Amsterdam, the Netherlands, University of Michigan, Ann Arbor, Michigan. Electronic address: tenwolde@amolf.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circadian clocks must be able to entrain to time-varying signals to keep their oscillations in phase with the day-night rhythm. On the other hand, they must also exhibit input compensation: their period must remain approximately one day in different constant environments. The posttranslational oscillator of the Kai system can be entrained by transient or oscillatory changes in the ATP fraction, yet is insensitive to constant changes in this fraction. We study in three different models of this system how these two seemingly conflicting criteria are met. We find that one of these (our recently published Paijmans model) exhibits the best tradeoff between input compensation and entrainability: on the footing of equal phase-response curves, it exhibits the strongest input compensation. Performing stochastic simulations at the level of individual hexamers allows us to identify a new, to our knowledge, mechanism, which is employed by the Paijmans model to achieve input compensation: at lower ATP fraction, the individual hexamers make a shorter cycle in the phosphorylation state space, which compensates for the slower pace at which they traverse the cycle.

Indexed as

Adenosine DiphosphateAdenosine TriphosphateBacterial ProteinsBinding SitesCircadian ClocksCircadian Rhythm Signaling Peptides and ProteinsComputer SimulationKineticsModels, BiologicalMonte Carlo MethodPhosphorylationProtein BindingProtein Processing, Post-TranslationalStochastic ProcessesSynechococcusAdenosine DiphosphateAdenosine TriphosphateBacterial ProteinsCircadian Rhythm Signaling Peptides and ProteinsKaiA protein, cyanobacteriaKaiB protein, cyanobacteriaKaiC protein, cyanobacteria

Identifiers

PMID28700914
PMCPMC5510911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.